Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wara

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The New England Journal of Medicine|November 3, 1994
A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials GroupS A Spector, R D Gelber, N McGrath, et al.
Pediatrics|April 1, 1997
A descriptive survey of pediatric human immunodeficiency virus-infected long-term survivorsK Nielsen, G McSherry, A Petru, et al.
The Journal of Infectious Diseases|August 1, 1994
Association between anti-human immunodeficiency virus type 1 (HIV-1) antibody-dependent cellular cytotoxicity antibody titers at birth and vertical transmission of HIV-1M Jenkins, D Landers, D Williams-Herman, et al.
Clinical and Diagnostic Laboratory Immunology|September 6, 2000
Shipment impairs lymphocyte proliferative responses to microbial antigensR A Betensky, E Connick, J Devers, et al.
The Journal of Infectious Diseases|November 9, 2000
Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study TeamW T Shearer, R J Israel, S Starr, et al.
The Journal of Infectious Diseases|March 18, 2000
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 CollaboratorsW Borkowsky, D Wara, T Fenton, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218)J S Lambert, J McNamara, S L Katz, et al.
Human Gene Therapy|February 27, 1999
Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA geneC Dunbar, L Chang, C Mullen, et al.
The Journal of Infectious Diseases|October 27, 2001
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccineE J McFarland, W Borkowsky, T Fenton, et al.
Nature Medicine|July 14, 1998
T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonatesD B Kohn, M S Hershfield, D Carbonaro, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The New England Journal of Medicine|November 3, 1994
A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials GroupS A Spector, R D Gelber, N McGrath, et al.
Pediatrics|April 1, 1997
A descriptive survey of pediatric human immunodeficiency virus-infected long-term survivorsK Nielsen, G McSherry, A Petru, et al.
The Journal of Infectious Diseases|August 1, 1994
Association between anti-human immunodeficiency virus type 1 (HIV-1) antibody-dependent cellular cytotoxicity antibody titers at birth and vertical transmission of HIV-1M Jenkins, D Landers, D Williams-Herman, et al.
Clinical and Diagnostic Laboratory Immunology|September 6, 2000
Shipment impairs lymphocyte proliferative responses to microbial antigensR A Betensky, E Connick, J Devers, et al.
The Journal of Infectious Diseases|November 9, 2000
Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study TeamW T Shearer, R J Israel, S Starr, et al.
The Journal of Infectious Diseases|March 18, 2000
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 CollaboratorsW Borkowsky, D Wara, T Fenton, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218)J S Lambert, J McNamara, S L Katz, et al.
Human Gene Therapy|February 27, 1999
Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA geneC Dunbar, L Chang, C Mullen, et al.
The Journal of Infectious Diseases|October 27, 2001
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccineE J McFarland, W Borkowsky, T Fenton, et al.
Nature Medicine|July 14, 1998
T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonatesD B Kohn, M S Hershfield, D Carbonaro, et al.
Pageof 4